External Advisory Board

The UW has a growing role in fostering economic activity in our region, and technology transfer is a visible measure of the impact of the UW’s research programs on our communities.  UW TechTransfer’s mission is to extend the impact of UW research through the creation of partnerships that encourage investment in innovation.  In that effort we have formed an external board to advise us on all aspects of the development and transfer of UW-generated discoveries.  Through the expertise of these leaders we look to improve how we identify and assess opportunities, gain insight into the venture and business development community, and enhance the flow of new discoveries to local companies. 

External Advisory Board Members:

Stephen D. Arnold, Managing Director, Polaris Venture Partners
Patricia Beckmann, Chief Scientific Officer, Homestead Clinical Corporation
Bruce Carter, President and Chairman, ZymoGenetics, Inc.
R. Lee Cheatham, Executive Director, Washington Technology Center
Joseph Eichinger, President, CoAptus Corporation
Patrick J. Ennis, Managing Director, ARCH Venture Partners
Greg Gottesman, Partner, Madrona Venture Group
Karen Hedine, President, CEO, Micronics, Inc
Ronald S. Howell, Managing Director, WRF Capital
Michael Kranda, Director, Biotechnology Venture Investments, Vulcan Capital
Scot E. Land, Managing Director, Technology Development Corporation
Robert T. Nelsen, Managing Director, ARCH Venture Partners
H. Stewart Parker, President and CEO, Targeted Genetics Corporation
J. Thomas Ranken, Founder and CEO, VizX Labs
Daniel Rosen, President and CEO, Dan Rosen & Associates
Katherine James Schuitemaker, CEO, The Resonance Group
Christopher Somogyi, Managing Director, Somogyi Ventures, LLC
Charles P. Waite, Jr., Managing Partner, OVP Venture Partners